ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
3 |
17/01/23 |
17/01/23 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
3 |
16/01/23 |
16/01/23 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
2 |
15/01/23 |
15/01/23 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
1 |
05/01/23 |
05/01/23 |
ASX - By Stock
|
3.2K
|
1.0M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
2 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
3.2K
|
1.0M
|
2
|
|
Humour
|
|
Re:
Art lovers....
|
|
mxdbg
|
1 |
876 |
4 |
04/01/23 |
04/01/23 |
Humour
|
1
|
876
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
2 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
2 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
2 |
03/01/23 |
03/01/23 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
50 cents On the Horizon ?
|
|
mxdbg
|
1.7K |
799K |
8 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
1.7K
|
799K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Cancel - Proposed issue of securities - BIT
|
|
mxdbg
|
7 |
2.8K |
3 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
7
|
2.8K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: $1.43M R&D rebate received
|
|
mxdbg
|
55 |
15K |
0 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
55
|
15K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: $1.43M R&D rebate received
|
|
mxdbg
|
55 |
15K |
0 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
55
|
15K
|
0
|
|
Humour
|
|
Re:
<: Anyone Here Drive An EV :--->
|
|
mxdbg
|
30 |
8.2K |
2 |
21/11/22 |
21/11/22 |
Humour
|
30
|
8.2K
|
2
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
mxdbg
|
408 |
135K |
2 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
408
|
135K
|
2
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
mxdbg
|
408 |
135K |
3 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
408
|
135K
|
3
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
mxdbg
|
408 |
135K |
14 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
408
|
135K
|
14
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron Share Price Competition Jan 1 2022
|
|
mxdbg
|
408 |
135K |
5 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
408
|
135K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
mxdbg
|
30 |
10K |
3 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
30
|
10K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
mxdbg
|
188 |
57K |
4 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
188
|
57K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
mxdbg
|
188 |
57K |
1 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
188
|
57K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
mxdbg
|
188 |
57K |
7 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
188
|
57K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
mxdbg
|
188 |
57K |
4 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
188
|
57K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Bill Gates &MG Foundation &BIOTRON
|
|
mxdbg
|
294 |
88K |
2 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
294
|
88K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
mxdbg
|
188 |
57K |
5 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
188
|
57K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
mxdbg
|
188 |
57K |
0 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
188
|
57K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
mxdbg
|
188 |
57K |
3 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
188
|
57K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
4 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
10 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
10
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
2 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
5 |
05/09/22 |
05/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
2 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
1 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
0 |
03/09/22 |
03/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
4 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
6 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
13K
|
6.3M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited
|
|
mxdbg
|
28 |
12K |
5 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
28
|
12K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Full Year Statutory Accounts and Appendix 4E
|
|
mxdbg
|
110 |
33K |
0 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
110
|
33K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Full Year Statutory Accounts and Appendix 4E
|
|
mxdbg
|
110 |
33K |
8 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
110
|
33K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
3 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
5 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
mxdbg
|
3.2K |
1.0M |
12 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
12
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
12 |
15/08/22 |
15/08/22 |
ASX - By Stock
|
13K
|
6.3M
|
12
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
mxdbg
|
13K |
6.3M |
1 |
13/08/22 |
13/08/22 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
mxdbg
|
171 |
49K |
4 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
171
|
49K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
mxdbg
|
171 |
49K |
2 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
171
|
49K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
mxdbg
|
171 |
49K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
171
|
49K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
mxdbg
|
171 |
49K |
9 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
171
|
49K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
mxdbg
|
171 |
49K |
0 |
02/08/22 |
02/08/22 |
ASX - By Stock
|
171
|
49K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Scripps Research study identifies existing drugs as potential COVID-19 therapies
|
|
mxdbg
|
171 |
49K |
3 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
171
|
49K
|
3
|
|